Washington, DC
P +1 (202) 442-3503
Select Section
Overview
Ian brings a precise, solutions-oriented approach to guiding clients through technically complex litigation matters.
Ian is an associate attorney with experience spanning patent, regulatory, and complex commercial disputes, with a particular focus on matters involving scientific and technical issues. Drawing on his background in biology and his work in major pharmaceutical patent cases, Ian excels at translating complicated subject matter into clear, strategic arguments that advance his clients’ business objectives.
Prior to joining Dorsey, Ian was an associate in the IP Litigation Group of a national law firm. Ian is committed to pro bono service, representing clients in civil rights and immigration cases.
Experience
Representative Work
- Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation; helped obtain favorable settlement for client. *
- Represented pharmaceutical manufacturer in Hatch-Waxman litigation; helped obtain favorable settlement and dismissal of all claims. *
- Represented pharmaceutical manufacturer in products liability multidistrict litigation; helped obtain dismissal of claims by numerous tribal entities and states. *
- Represented civil rights pro bono client in litigation against state prison officials; overcame multiple motions to dismiss and motion for summary judgment. *
* Experience occurred prior to joining Dorsey.
News & Resources
- Potential Shifts in Section 337 Precedent: What The Data Tells Us, IP Watchdog (2024)
- Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA, Food & Drug Law Institute Spring 2024 Update
- Del. IP Ruling May Mark Limitation-By-Limitation Analysis Shift, Law360 (2024)
- Chapter 12: Discovery, ANDA Litigation: Strategies for Pharmaceutical Patent Litigators, Fourth Edition